[go: up one dir, main page]

GB202216558D0 - New antibacterial products - Google Patents

New antibacterial products

Info

Publication number
GB202216558D0
GB202216558D0 GBGB2216558.3A GB202216558A GB202216558D0 GB 202216558 D0 GB202216558 D0 GB 202216558D0 GB 202216558 A GB202216558 A GB 202216558A GB 202216558 D0 GB202216558 D0 GB 202216558D0
Authority
GB
United Kingdom
Prior art keywords
new antibacterial
antibacterial products
products
new
antibacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2216558.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Liverpool
Original Assignee
University of Liverpool
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Liverpool filed Critical University of Liverpool
Priority to GBGB2216558.3A priority Critical patent/GB202216558D0/en
Publication of GB202216558D0 publication Critical patent/GB202216558D0/en
Priority to PCT/GB2023/052905 priority patent/WO2024100391A2/en
Priority to EP23806368.9A priority patent/EP4615855A2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB2216558.3A 2022-11-07 2022-11-07 New antibacterial products Ceased GB202216558D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB2216558.3A GB202216558D0 (en) 2022-11-07 2022-11-07 New antibacterial products
PCT/GB2023/052905 WO2024100391A2 (en) 2022-11-07 2023-11-07 New antibacterial products
EP23806368.9A EP4615855A2 (en) 2022-11-07 2023-11-07 New antibacterial products

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2216558.3A GB202216558D0 (en) 2022-11-07 2022-11-07 New antibacterial products

Publications (1)

Publication Number Publication Date
GB202216558D0 true GB202216558D0 (en) 2022-12-21

Family

ID=84839834

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2216558.3A Ceased GB202216558D0 (en) 2022-11-07 2022-11-07 New antibacterial products

Country Status (3)

Country Link
EP (1) EP4615855A2 (en)
GB (1) GB202216558D0 (en)
WO (1) WO2024100391A2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140121168A1 (en) * 2011-04-26 2014-05-01 Antagonists Of Trpv1 Receptor Antagonists of trpv1 receptor
US11046730B2 (en) * 2016-04-15 2021-06-29 The Regents Of The University Of California Antimicrobial compositions
ES2981759T3 (en) 2017-04-04 2024-10-10 Novobiotic Pharmaceuticals Llc New depsipeptides and their uses
EP3872084A1 (en) * 2020-02-27 2021-09-01 Universität Ulm Epi-x4 based peptides and derivatives thereof

Also Published As

Publication number Publication date
WO2024100391A2 (en) 2024-05-16
WO2024100391A3 (en) 2024-08-02
EP4615855A2 (en) 2025-09-17

Similar Documents

Publication Publication Date Title
GB202202060D0 (en) Product
GB2623583B (en) Construction Product
GB202000962D0 (en) Building product
GB201908108D0 (en) Product
GB202216558D0 (en) New antibacterial products
GB201903318D0 (en) Product
GB202315614D0 (en) Antibacterial
GB202304491D0 (en) Product
GB202304454D0 (en) Product
GB202302255D0 (en) Product
GB202218144D0 (en) Product
GB202216674D0 (en) Product
GB202215233D0 (en) Product
GB202214756D0 (en) Product
GB202211637D0 (en) Product
GB202209424D0 (en) Product
GB202215631D0 (en) Construction product
GB202206176D0 (en) Product
CA210381S (en) Biscuit
CA210382S (en) Biscuit
CA210379S (en) Biscuit
CA210380S (en) Biscuit
CA220545S (en) Absorbent product
GB202104148D0 (en) Product
GB202101453D0 (en) Product

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)